Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/48745Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Tannock, Ian F. | - |
| dc.contributor.author | BUYSE, Marc | - |
| dc.contributor.author | De Backer, Mickael | - |
| dc.contributor.author | Earl, Helena | - |
| dc.contributor.author | Goldstein, Daniel A. | - |
| dc.contributor.author | Ratain, Mark J. | - |
| dc.contributor.author | Saltz, Leonard B. | - |
| dc.contributor.author | Sonke, Gabe S. | - |
| dc.contributor.author | Strohbehn, Garth W. | - |
| dc.date.accessioned | 2026-03-13T13:09:55Z | - |
| dc.date.available | 2026-03-13T13:09:55Z | - |
| dc.date.issued | 2025 | - |
| dc.date.submitted | 2026-03-09T16:16:07Z | - |
| dc.identifier.citation | The Lancet Oncology, 378 (1) , p. e8 | - |
| dc.identifier.uri | http://hdl.handle.net/1942/48745 | - |
| dc.language.iso | en | - |
| dc.publisher | ELSEVIER SCIENCE INC | - |
| dc.title | Non-inferiority trials: tyranny or good governance? Reply | - |
| dc.type | Journal Contribution | - |
| dc.identifier.issue | 1 | - |
| dc.identifier.spage | e8 | - |
| dc.identifier.volume | 378 | - |
| local.format.pages | 1 | - |
| local.bibliographicCitation.jcat | A1 | - |
| dc.description.notes | Tannock, IF (corresponding author), Univ Toronto, Princess Margaret Canc Ctr, Div Med Oncol, Toronto, ON M5G 2M9, Canada.; Tannock, IF (corresponding author), Optimal Canc Care Alliance, Ann Arbor, MI 48126 USA. | - |
| dc.description.notes | ian.tannock@uhn.ca | - |
| local.publisher.place | STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA | - |
| local.type.refereed | Refereed | - |
| local.type.specified | Letter | - |
| local.class | dsPublValOverrule/author_version_not_expected | - |
| dc.identifier.doi | 10.1016/S1470-2045(24)00717-4 | - |
| dc.identifier.isi | 001696610900001 | - |
| local.provider.type | wosris | - |
| local.description.affiliation | [Tannock, Ian F.] Univ Toronto, Princess Margaret Canc Ctr, Div Med Oncol, Toronto, ON M5G 2M9, Canada. | - |
| local.description.affiliation | [Tannock, Ian F.; Goldstein, Daniel A.; Ratain, Mark J.; Saltz, Leonard B.; Strohbehn, Garth W.] Optimal Canc Care Alliance, Ann Arbor, MI 48126 USA. | - |
| local.description.affiliation | [Buyse, Marc; De Backer, Mickael] Int Drug Dev Inst, Louvain La Neuve, Belgium. | - |
| local.description.affiliation | [Buyse, Marc] Hasselt Univ, I BioStat, Hasselt, Belgium. | - |
| local.description.affiliation | [Earl, Helena] Univ Cambridge, Dept Oncol, Cambridge, England. | - |
| local.description.affiliation | [Goldstein, Daniel A.] Rabin Med Ctr, Davidoff Canc Ctr, Petah Tiqwa, Israel. | - |
| local.description.affiliation | [Goldstein, Daniel A.] Clalit Hlth Serv, Tel Aviv, Israel. | - |
| local.description.affiliation | [Goldstein, Daniel A.] Tel Aviv Univ, Fac Med, Tel Aviv, Israel. | - |
| local.description.affiliation | [Ratain, Mark J.] Univ Chicago, Dept Med, Sect Hematol Oncol, Chicago, IL USA. | - |
| local.description.affiliation | [Saltz, Leonard B.] Mem Sloan Kettering Canc Ctr, Dept Med, Gastrointestinal Oncol Serv, New York, NY USA. | - |
| local.description.affiliation | [Sonke, Gabe S.] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands. | - |
| local.description.affiliation | [Sonke, Gabe S.] Univ Amsterdam, Amsterdam, Netherlands. | - |
| local.description.affiliation | [Strohbehn, Garth W.] Charles S Kettles VA Med Ctr, Vet Affairs Centerfor Clin Management Res, Ann Arbor, MI USA. | - |
| local.description.affiliation | [Strohbehn, Garth W.] Univ Michigan, Inst Hlth Policy & Innovat, Rogel Canc Ctr, Div Oncol,Div Hematol Oncol, Ann Arbor, MI USA. | - |
| local.description.affiliation | [Strohbehn, Garth W.] Univ Michigan, Inst Hlth Policy & Innovat, Rogel Canc Ctr,Div Hematol Oncol, Lung Precis Oncol Program, Ann Arbor, MI USA. | - |
| local.description.affiliation | [Strohbehn, Garth W.] Ctr Global Hlth Equ, Ann Arbor, MI USA. | - |
| local.uhasselt.international | yes | - |
| item.fullcitation | Tannock, Ian F.; BUYSE, Marc; De Backer, Mickael; Earl, Helena; Goldstein, Daniel A.; Ratain, Mark J.; Saltz, Leonard B.; Sonke, Gabe S. & Strohbehn, Garth W. (2025) Non-inferiority trials: tyranny or good governance? Reply. In: The Lancet Oncology, 378 (1) , p. e8. | - |
| item.fulltext | With Fulltext | - |
| item.accessRights | Restricted Access | - |
| item.contributor | Tannock, Ian F. | - |
| item.contributor | BUYSE, Marc | - |
| item.contributor | De Backer, Mickael | - |
| item.contributor | Earl, Helena | - |
| item.contributor | Goldstein, Daniel A. | - |
| item.contributor | Ratain, Mark J. | - |
| item.contributor | Saltz, Leonard B. | - |
| item.contributor | Sonke, Gabe S. | - |
| item.contributor | Strohbehn, Garth W. | - |
| crisitem.journal.issn | 1470-2045 | - |
| crisitem.journal.eissn | 1474-5488 | - |
| Appears in Collections: | Research publications | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| main.pdf Restricted Access | Published version | 25.18 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.